Comparison of M-TAPA and TAP Blocks on Postoperative Analgesia in Laparoscopic Appendectomy Surgeries
Launched by CUMHURIYET UNIVERSITY · Jul 1, 2024
Trial Information
Current as of May 30, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is examining two different methods of pain relief for patients who are having laparoscopic appendectomy surgeries, which are minimally invasive surgeries to remove the appendix. The two methods being compared are called M-TAPA block and TAP block, both of which aim to help reduce pain after the surgery. The study will help determine which method works better for managing post-operative pain.
To participate in this trial, you need to be an adult over the age of 18 who is scheduled for a laparoscopic appendectomy. You should be in good health according to the American Society of Anesthesiologists' classification, which evaluates your overall health and risk during surgery. However, there are some reasons you might not be eligible, such as having certain medical conditions or allergies. If you decide to join the study, you'll receive one of the pain relief methods and will be monitored to see how well it works for you after your surgery. Please note that this trial is not yet recruiting participants, so it may be a while before you can sign up.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients older than 18 years of age who will undergo laparoscopic appendectomy under general anesthesia and will be American Society of Anesthesiologists (ASA) I-II-III according to the ASA risk classification.
- Exclusion Criteria:
- • Patients who did not give consent,
- • patients with coagulopathy,
- • patients with signs of infection at the block application site,
- • patients using anticoagulants,
- • patients with local anesthetic drug allergies,
- • patients undergoing open surgery,
- • patients with unstable hemodynamics,
- • patients who could not cooperate during postoperative pain assessment
About Cumhuriyet University
Cumhuriyet University is a distinguished academic institution located in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies that aim to enhance healthcare outcomes. With a focus on interdisciplinary collaboration, Cumhuriyet University fosters an environment conducive to rigorous scientific inquiry and ethical research practices, ensuring that trials conducted under its auspices adhere to the highest standards of quality and integrity. Through its dedicated efforts, the university contributes significantly to the global body of medical knowledge and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Oğuz Gündoğdu
Principal Investigator
Sivas Cumhuriyet University School of Medicine, Anesthesiology and Reanimation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported